BioXell: Research Update Milan, Italy, Nov. 29, 2004 (PRIMEZONE) -- BioXell to commence phase IIa trial of its lead compound, BXL628, in Overactive Bladder Milan, Italy, 29 November, 2004 - BioXell SpA, today announced...

BioXell raises EUR 23m in its Third Round of Private Financing MILAN, Italy, Oct. 20, 2004 (PRIMEZONE) -- BioXell today announced that it has completed a private financing round raising euro23m. The funding, led by the international life science investor BB...

BioXell Announces Acquisition of Rights MILAN, Italy, June 29, 2004 (PRIMEZONE) -- BioXell today announced that it has purchased additional indications from Roche for lead compound BXL 628 which, under the original agreement, was licensed...